Market by Product Type, Application, and Country Outlook | Forecast 2022-2028
As per Triton’s report, the
market for medical enzymes in the Asia-Pacific is estimated to advance with a CAGR of 7.67% over the forecasting
duration from 2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries analyzed in this region include:
• South Korea
• ASEAN Countries
• China
• India
• Japan
• Australia & New
Zealand
• Rest of Asia-Pacific
One of the main factors projected to fuel the expansion of the medical
enzymes market in the Asia-Pacific is the poor dietary habits of individuals in
nations like China, India, and Japan. Poor eating habits have contributed to a
number of health problems, including weight gain and digestive ailments in the
region. This has led to an increased demand for medical enzymes for treatment, and
is expected to foster the market’s growth in the forthcoming years.
The prevalence of hypertension, diabetes, and cardiovascular illnesses
is on the rise in China. These conditions can be treated and managed using
medical enzymes. Thus, the country’s medical enzymes market is anticipated to
grow as a result of rising disease rates. Other factors, including the
expanding biotech industry, development of healthcare infrastructure, and a
vast population, also support the market’s growth.
South Korea is faced with challenges, such as the nation’s increasingly
aging population, high rates of childhood obesity and harmful health behaviors
like smoking & drinking, which need to be addressed. The majority of the
diseases affecting Koreans are non-communicable, including Alzheimer’s, liver
and lung cancer, heart disease, and cerebrovascular disease. The use of enzymes
in the treatment of various illnesses is thus anticipated to fuel the studied
market’s expansion in the coming years.
Digestive enzymes can break down lipids, proteins, and carbohydrates. A
few examples include maltase, amylase, sucrose, peptidase, lipase, nuclease,
and other enzymes. Their usage in the treatment of digestive problems, like
lactose intolerance, to cystic fibrosis and pancreatic insufficiency, increases
the market segment’s potential for growth. During the projected period, the
rising elderly population, increased awareness, and the rising incidence of
gastrointestinal illnesses such as constipation & irritable bowel syndrome
will all contribute to this segment’s growth.
The report assesses the market based on
application and product type. Here, the product type segment is divided into digestive enzyme,
hydrolase, thrombolytic enzyme, and endonuclease.
The eminent players in the medical enzymes
market include Advanced Enzymes, BASF SE, Thermofisher Scientific Inc,
Novozymes, Sanofi SA, Codexis, and Novus.
Advanced Enzymes is one of the biggest enzyme producers in India. It
produces, markets, and engages in research & development of more than 400
products derived from roughly 65 local enzymes and probiotics. Human nutrition,
animal nutrition, probiotics, food processing, and non-food processing sectors
are the company’s main business segments. Advanced Enzymes has 5 manufacturing
facilities, 4 fully-owned direct subsidiaries, 5 step-down fully-owned
subsidiaries, and 3 partially owned subsidiaries. Founded in 1989, the company
is headquartered in Thane, Maharashtra.
Key deliverables of the report:
● Market CAGR during the forecasting years 2022-2028
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the medical enzymes market revenue growth in Asia-Pacific and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model
● A wide-ranging study of factors that will challenge the Asia-Pacific
medical enzymes market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this
report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
MEDICAL ENZYMES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE MEDICAL ENZYMES MARKET
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN ENZYME ENGINEERING
2.2.2. INCREASED
DEMAND IN THE PHARMACEUTICAL SECTOR
2.3. PORTER'S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. PRICE
2.4.2. QUALITY
2.4.3. USAGE
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.7.1. RESEARCH
AND DEVELOPMENT
2.7.2. OPERATIONS
2.7.3. OUTBOUND
LOGISTICS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES & DEVELOPMENTS
2.9.3. PARTNERSHIPS
& AGREEMENTS
2.9.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.10. MARKET DRIVERS
2.10.1. RISING INVESTMENTS IN RESEARCH
AND DEVELOPMENT
2.10.2. RISING AGING POPULATION AND
OCCURRENCE OF CHRONIC DISEASES
2.10.3. INCREASING APPLICATIONS IN THE
PHARMACEUTICAL INDUSTRY
2.11. MARKET CHALLENGES
2.11.1. STRICT REGULATIONS
2.11.2. SAFETY CONCERNS WHILE HANDLING
ENZYMES
2.12. MARKET OPPORTUNITIES
2.12.1. RISING HEALTH ISSUES AND
GROWING AWARENESS
2.12.2. RISING DEMAND FOR SPECIALTY
ENZYMES
3. ASIA-PACIFIC
MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE
3.1. HYDROLASE
3.1.1. HYALURONIDASE
3.1.2. LYSOZYMES
3.1.3. OTHER
HYDROLASES ENZYMES
3.2. THROMBOLYTIC
ENZYME
3.2.1. STREPTOKINASE
3.2.2. UROKINASE
3.2.3. OTHER
THROMBOLYTIC ENZYMES
3.3. DIGESTIVE
ENZYME
3.3.1. LACTASE
3.3.2. L-ASPARAGINASE
3.3.3. OTHER
DIGESTIVE ENZYMES
3.4. ENDONUCLEASE
3.4.1. BENZONASE
3.4.2. OTHER
ENDONUCLEASES
4. ASIA-PACIFIC
MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION
4.1. DISEASE
TREATMENT
4.2. DIAGNOSTIC
TOOLS
4.3. BIOMEDICAL
RESEARCH
4.4. OTHER
APPLICATIONS
5. ASIA-PACIFIC
MEDICAL ENZYMES MARKET – COUNTRY OUTLOOK
5.1. CHINA
5.2. JAPAN
5.3. INDIA
5.4. SOUTH
KOREA
5.5. ASEAN
COUNTRIES
5.6. AUSTRALIA
& NEW ZEALAND
5.7. REST
OF ASIA-PACIFIC
6. COMPETITIVE
LANDSCAPE
6.1. BASF
SE
6.2. DUPONT
6.3. ROCHE
HOLDING AG
6.4. NOVOZYMES
6.5. DSM
6.6. SANOFI
SA
6.7. CODEXIS
6.8. ADVANCED
ENZYMES
6.9. AMANO
ENZYME
6.10. BBI SOLUTIONS
6.11. THERMOFISHER SCIENTIFIC INC
6.12. CPC BIOTECH
6.13. NOVUS
6.14. BRAIN BIOTECH AG
6.15. SEKISUI
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES OF DATA
7.3. RESEARCH METHODOLOGY
TABLE 1: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: APPLICATIONS
OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY
TABLE 3: VENDOR
SCORECARD
TABLE 4: REGULATORY
FRAMEWORK
TABLE 5: LIST OF
MERGERS & ACQUISITIONS
TABLE 6: LIST OF
PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: LIST OF
PARTNERSHIPS & AGREEMENTS
TABLE 8: LIST OF
BUSINESS EXPANSIONS & DIVESTITURES
TABLE 9: MEDICAL
APPLICATION OF VARIOUS ENZYMES
TABLE 10: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING
IMPACT ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)
FIGURE 7: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN %)
FIGURE 12: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)
FIGURE 17: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY ENDNUCLEASE ENZYME, 2021 & 2028 (IN %)
FIGURE 22: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 25: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 30: CHINA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: JAPAN
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: INDIA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: SOUTH KOREA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: ASEAN
COUNTRIES MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: AUSTRALIA
& NEW ZEALAND MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: REST OF
ASIA-PACIFIC MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)